Aminoglycosides have been reported as alternative therapy for chancroid, a sexually transmitted disease caused by Haemophilus ducreyi. This bacterium was found to be highly susceptible to streptomycin in vitro as early as 1946 (26) , and its susceptibility to aminoglycosides was confirmed in vivo by the successful treatment of chancroid with streptomycin (4), kanamycin (25) , and gentamicin (23) .
Recently, however, treatment failures have been reported, accompanied by in vitro resistance in H. ducreyi to streptomycin and kanamycin in Singapore (31) and, additionally, to gentamicin in Amsterdam (36) . A high frequency of kanamycin resistance has also been reported in strains of H. ducreyi from Thailand (37) , but the mechanisms of resistance were not studied. During 1982 and 1983, we isolated, in Paris, three strains that were resistant to streptomycin and kanamycin from genital lesions of three male patients. These strains also produced a beta-lactamase and a chloramphenicol acetyltransferase, and they were resistant to tetracycline.
Aminoglycoside resistance has been shown previously to be plasmid mediated in other species of Haemophilus (9) and due to the presence of aminoglycoside-modifying enzymes (22) . In H. ducreyi, plasmid-mediated resistance to ampicillin (3, 7), sulfonamides (1), and tetracycline (2) has been demonstrated. In light of these studies, we have searched for aminoglycoside-modifying enzymes in the resistant strains of H. ducreyi and tried to relate the resistance to plasmids present in these strains.
(This study was presented in part at the 24th Interscience Conference on Antimicrobial Agents and Chemotherapy, 1984, Washington, D.C., abstr. no. 946).
MATERIALS AND METHODS
Bacterial strains and growth conditions. The bacterial strains used in this study are listed in Table 1 neuve-la-Garenne, France). All incubations were at 37°C in a 5% CO2 humid atmosphere. The three H. ducreyi isolates were identified on the basis of colonial, morphological, and biochemical characteristics (8, 17) .
Testing of antibiotic susceptibility and of antibioticinactivating enzymes. Antibiotic susceptibility was tested by an agar dilution method as previously described (33) . Betalactamase production was detected by use of the rapid chromogenic cephalosporin test (28) on filter paper (BioMerieux, Charbonnieres les Bains, France). Chloramphenicol acetyltransferase activity was assayed as previously described (32) . Characterization of outer membrane proteins. Total membranes from cells, after 24 h of growth and sonication (six bursts of 30 s, in ice), were prepared essentially as previously described (35) . Sarkosyl-insoluble outer membranes (34) were prepared after incubation of ca. 100 ,ug of total membrane protein in 200 ,ul of 10 mM phosphate buffer (pH 7) containing 0.3% of Sarkosyl NL-97 for 30 min at room temperature and centrifugation at 40,000 x g for 45 min at 20°C. The pellet was suspended in sample buffer, boiled for 5 min, and subjected to polyacrylamide gel electrophoresis in sodium dodecyl sulfate as previously described (20) .
Assay of aminoglycoside-modifying enzymes and gel filtration. H. ducreyi cells were grown for 24 h in liquid medium, 100,000 x g supernatants (S 100) were prepared after sonication (as above), and the enzymes were assayed with radioactive cofactors (see below) and binding of the modified antibiotics to phosphocellulose (Whatman P 81) as described by Haas and Dowding (14) . S 100 from strain HD83011 was fractionated by filtration through a column of AcA54 (Reactifs IBF, Villeneuve-la-Garenne, France) equilibrated with buffer (50 mM Tris-hydrochloride, 10 mM MgCl, 200 mM NH4Cl, 14 mM P-mercaptoethanol [pH 7 .4]).
Electroblotting of S 100 proteins and reaction with anti-APH antisera. S 100 proteins were separated by electrophoresis (20) and electrophoretically transferred to nitrocellulose sheets (Schleicher & Schuell BA85) under the conditions described by Towbin et al. (38) , except that the buffer contained 1% sodium dodecyl sulfate for 12 to 14 h, and no sodium dodecyl sulfate for 2 to 3 h, at 8 V/cm. Blocking of the nitrocellulose with bovine serum albumin (27) .
(5%; overnight), reaction with antisera against purified 3',5"-aminoglycoside phosphotransferase of type I [APH(3',5")-I] and APH(3')-II raised in rabbits (E. Collatz, unpublished data) and with horseradish peroxidase-conjugated goat antirabbit immunoglobulin G (Nordic), and development with 4-chloro-1-naphthol (Merck) were carried out as described by Hawkes et al. (16) .
Isolation of plasmid DNA, agarose gel electrophoresis, and bacterial transformation. The procedures described by Maniatis et al. (24) were followed. The alkaline lysis method was used for the rapid isolation of plasmid DNA, except that H. ducreyi cells were harvested from solid medium, agarose gel electrophoresis was performed in Tris-acetate buffer, and DNA was purified after electroelution into a trough cut into the agarose gel. The calcium chloride procedure was used for the transformation of Escherichia coli BM694 (19) . Transformants were selected on LB agar containing streptomycin (30 ,ug/ml) or neomycin (50 jig/ml). The resistance phenotypes of the transformants were assayed by disk diffusion susceptibility testing on Mueller-Hinton agar. the enzyme activities were not completely separated (Fig. 3) , it is apparent from the elution profile that two distinct phosphotransferases were present. The reason for the appearance of two peaks for the streptomycin-phosphorylating enzyme, and the site which it modifies, has not been studied. From an S 100 preparation of HB83011, a fraction devoid of streptomycin phosphotransferase activity was eluted from a column of immobilized kanamycin (data not shown). This preparation contained a phosphotransferase which modified neomycin and lividomycin to the extent shown in Fig. 2 , but not butirosin, tobramycin, amikacin, gentamicin, sisomicin, netilmicin, apramicin, hygromycin, fortimicin, or spectinomycin, which is in agreement with the substrate profile of an APH(3',5")-I.
To characterize the kanamycin phosphotransferase further, we probed the S 100 proteins with antisera raised against the APH(3',5")-I encoded by Tn6OJ(903) (10) and the APH(3')-II encoded by TnS (5) after electrophoretic separation and transfer to nitrocellulose sheets (Fig. 4) . In the three H. ducreyi strains, one protein, which comigrated with the purified APH(3',5")-I, reacted with the corresponding anti- body. There was, however, no noticeable reaction with the anti-APH(3')-II serum.
Association of aminoglycoside resistance and plasmid DNA. Extrachromosomal DNA was prepared from the three aminoglycoside-resistant strains by alkaline lysis and used to transform E. coli. Transformants selected in the presence of either streptomycin or kanamycin were resistant to both drugs but susceptible to gentamicin, ampicillin, chloramphenicol, and tetracycline. Each transformant had acquired a small plasmid (Fig. 5 ) of ca. 4.7 kilobases (data not shoown). To ascertain that both resistance markers were carried by the 4.7-kilobase plasmid and not by DNA with lower mobility, which probably corresponded to different forms of that plasmid (Fig. 5) (31, 36) and may be explained by resistance mechanisms similar to those reported here.
In three multiply drug-resistant strains of H. ducreyi belonging to at least two subtypes (29, 37) , as inferred from their outer membrane protein profiles, we found streptomycin and kanamycin resistance to be mediated by a 4.7-kilobase plasmid and due to the synthesis of two APHs. The streptomycin-phosphorylating activity was not characterized further. The kanamycin-modifying enzyme was an APH(3',5")-I, as inferred from its substrate profile (11) and immunological cross-reactivity with the phosphotransferase encoded by Tn601(903) (10) . This is the second observation of a double resistance linked to one plasmid in H. ducreyi, after the recognition of a linked tetracycline-chloramphenicol resistance in one strain (2).
The 3',5"-phosphotransferases of type I are widespread among gram-negative bacteria (11) and frequently encoded on transposable elements (10, 18) . We have not specifically searched for the presence of transposons, but it appears that the APH(3',5")-I is not encoded by Tn903 since no PvuII fragments were found after endonuclease digestion of the 4.7-kilobase plasmid (data not shown). There are, however four PvuII sites on Tn903 (13) . One typical and one variant APH(3',5")-I, both plasmid mediated, have been described in strains of Haemophilus species other than H. ducreyi (9, 22) .
Since the original reports (31, 36) , a high frequency of kanamycin resistance has been reported in strains of H. ducreyi from Thailand, but no information was provided about the resistance mechanism or the mode of transfer (37) . We have carried out plasmid transfer only to E. coli, and by transformation, to identify the aminoglycoside resistance plasmid. It should be interesting to know whether there is resistance transfer by conjugation and whether such a transfer would be dependent on a mobilizing plasmid (12) . Furthermore, a structural comparison with the small betalactamase-specifying plasmids in H. ducreyi and Neisseria gonorrhoeae, the probably related cryptic plasmids of H. parainfluenzae (6) , as well as the small cryptic plasmid in N. gonorrhoeae should provide material for speculation on the origin of the aminoglycoside resistance plasmid in H. ducreyi.
The emergence and spread of antibiotic resistance plasmids among H. ducreyi have made ineffective several standard regimens for the treatment of chancroid, i.e., ampicillin (15) , sulfonamides (25) , tetracycline (25) , chloramphenicol (21) , and possibly trimethoprim (37) . The alternative treatment with aminoglycosides should not be considered unless the susceptibility of isolates is carefully established.
No resistance to macrolides has been detected as yet in H. ducreyi. Therefore, third-generation cephalosporins, erythromycin and cotrimoxazole, which remain active on sulfonamide-resistant H. ducreyi (30) , provide the most effective therapy of chancroid. In light of the decreasing number of useful antibiotics, it would seem reasonable to study the susceptibility of H. ducreyi to the newer quinolones.
